These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29228653)
1. Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma. Miao C; Liang C; Tian Y; Xu A; Zhu J; Zhao K; Zhang J; Hua Y; Liu S; Dong H; Zhang C; Su S; Li P; Qin C; Wang Z Oncotarget; 2017 Nov; 8(58):97811-97821. PubMed ID: 29228653 [TBL] [Abstract][Full Text] [Related]
2. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma. Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205 [TBL] [Abstract][Full Text] [Related]
3. The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma. Li X; Tang J; Huang W; Wang F; Li P; Qin C; Qin Z; Zou Q; Wei J; Hua L; Yang H; Wang Z Oncotarget; 2017 Nov; 8(56):96103-96116. PubMed ID: 29221190 [TBL] [Abstract][Full Text] [Related]
4. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway. Jia YY; Yu Y; Li HJ J Cancer; 2021; 12(14):4183-4195. PubMed ID: 34093819 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
6. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325 [TBL] [Abstract][Full Text] [Related]
7. TGFBI promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR/HIF-1α pathway. Zhan S; Bai X; Zhao Y; Tuoheti K; Yisha Z; Zuo Y; Lu P; Liu T Cancer Cell Int; 2024 Jul; 24(1):265. PubMed ID: 39068456 [TBL] [Abstract][Full Text] [Related]
8. CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma. Yu Y; Liang C; Wang S; Zhu J; Miao C; Hua Y; Bao M; Cao Q; Qin C; Shao P; Wang Z Oncotarget; 2018 Mar; 9(17):13313-13323. PubMed ID: 29568359 [TBL] [Abstract][Full Text] [Related]
9. Aberrant Expression of miR-592 Is Associated with Prognosis and Progression of Renal Cell Carcinoma. Lv X; Shen J; Guo Z; Kong L; Zhou G; Ning H Onco Targets Ther; 2019; 12():11231-11239. PubMed ID: 31908489 [TBL] [Abstract][Full Text] [Related]
10. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells. Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism. Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755 [TBL] [Abstract][Full Text] [Related]
12. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma. Wang H; Chen B; Duan B; Zheng J; Wu X Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195 inhibits proliferation and metastasis in renal cell carcinoma via regulating HMGA1. Dong H; Sun S; Yan T; Liang C; Zhu J; Miao C; Qin C; Shao P; Wang Z; Li J; Li P Am J Transl Res; 2020; 12(6):2781-2792. PubMed ID: 32655809 [TBL] [Abstract][Full Text] [Related]
14. Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma. Chen Z; Zhang Y; Wu X; Zhang J; Xu W; Shen C; Zheng B Onco Targets Ther; 2021; 14():2941-2952. PubMed ID: 33976552 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP). Gu C; Wang Z; Jin Z; Li G; Kou Y; Jia Z; Yang J; Tian F Oncotarget; 2017 Nov; 8(54):92119-92133. PubMed ID: 29190902 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells. Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297 [TBL] [Abstract][Full Text] [Related]
17. Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma. Li P; Tao L; Yang J; Cai H; Ju X; Li J; Shao P; Cao Q; Qin C; Meng X; Yin C Urology; 2013 Jul; 82(1):253.e1-7. PubMed ID: 23688375 [TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival. Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257 [TBL] [Abstract][Full Text] [Related]
19. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma. Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476 [TBL] [Abstract][Full Text] [Related]
20. TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma. Xiao R; Shen S; Yu Y; Pan Q; Kuang R; Huang H Int J Clin Exp Pathol; 2019; 12(1):305-312. PubMed ID: 31933746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]